{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.5","upperLimit":"18.8","value":"7.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Overall Survival (OS) defined as time from treatment initiation to death, will be described with use of Kaplan Meier curve.","dispersionType":"95% Confidence Interval","groups":[{"description":"One ARG1-vaccine every third week for 45 weeks.\n\nARG1-18,19,20: 300 ug ARG1-18,19,20 peptide in water mixed with 500ul montanide","id":"OG000","title":"ARG1-18,19,20 Peptide Vaccine"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"0 - 75 weeks","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}